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Abstract
A previous study identified a 348-bp region at the 5 end of the 8.5-kb latency-associated transcript (LAT) of HSV-1 strain 17Syn that
is necessary for maximum adrenergically induced reactivation following transcorneal iontophoresis of epinephrine (D.C. Bloom et al., 1996,
J. Virol. 70, 2449–2459). In that study, the construct with complete deletion of the 348-bp region, 17348, failed to achieve the high
reactivation frequency demonstrated by the parent (17Syn) and rescued (17348R) viruses. To further characterize the function of the
348-bp region, we analyzed two genetic constructs with partial deletions in the same 348-bp region, 17201 and 17207, in the rabbit
model. Both constructs exhibited the same high reactivation frequencies demonstrated by the parent 17Syn and the rescued 17348R
viruses. These results suggest that the control of reactivation is distributed over a large portion of the 348-bp region, rather than being
confined within a smaller, more discrete region. To assess whether the low reactivation phenotype of the 17348 construct was caused by
a requirement for proper spacing of elements outside the 348-bp region, we constructed a virus (17348St) that contained a 360-bp stuffer
fragment of heterologous DNA (lacZ) to maintain the proper spacing. The 17348St construct also displayed a low reactivation phenotype,
similar to that of 17348, suggesting that the effect of deleting this segment of the 5 exon of LAT is obtained through a mechanism other
than the disruption of spacing.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
In humans, herpes simplex virus type 1 (HSV-1) estab-
lishes life-long latency in sensory nerve ganglia. Episodes
of reactivation that occur in response to various stress stim-
uli (Wagner et al., 1975; Kwon et al., 1981; Haruta et al.,
1988; Sawtell and Thompson, 1992; Danaher et al., 1999)
lead to recurrent disease. The precise mechanism governing
the establishment and maintenance of latency and the fac-
tors that induce reactivation have been the subject of con-
siderable study. Initiation of reactivation begins with tran-
scription from a transcriptionally silenced genome. Of the
more than 70 genes expressed by HSV-1, only one family of
transcripts, the latency-associated transcripts (LATs), is
readily detected in latency (Wagner et al., 1988a,b; Kramer
and Coen, 1995; Bloom et al., 1996). Since the 3 end of the
major LAT overlaps the 3 end of ICP0, it may be that an
antisense mechanism regulates reactivation (Croen et al.,
1987; Rock et al., 1987; Stevens et al., 1987; Wechsler et
al., 1988a; Krause et al., 1988; Farrell et al., 1991). How-
ever, insertion of Poly(A) at several sites within the 3 end
of LAT, which terminates transcription, has no effect on
reactivation (Bloom et al., 1996). Furthermore, a LAT mu-
tant capable of expressing only the first 1.5 kb of LAT, a
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region that does not overlap ICP0, shows normal, wild-type
levels of spontaneous reactivation in rabbits (Perng et al.,
1996b). Thus LAT appears to have no antisense regulatory
mechanism.
LAT transcription-negative mutants demonstrate low
levels of induced (Bloom et al., 1994; Perng et al., 1994)
and spontaneous (Perng et al., 1994) reactivation in rabbits.
Thus LATs facilitate efficient in vivo reactivation. The
primary LAT transcript, which is 8.3 kb in size, gives rise to
a family of LAT RNAs that include a very stable 2-kb LAT
and a stable 1.5-kb LAT (Croen et al., 1987; Rock et al.,
1987; Stevens et al., 1987; Gordon et al., 1988; Spivack and
Fraser, 1988; Steiner et al., 1988; Wagner et al., 1988a,b;
Wechsler et al., 1988a,b, 1989; Zwaagstra et al., 1990).
LAT promoter mutants, which express no detectable
major LAT during latency, demonstrate a universal reduc-
tion in the ability to reactivate both spontaneously and after
induction in mouse and rabbit models (Hill et al., 1990;
Cook et al., 1991; Trousdale et al., 1991; Bloom et al., 1994;
Perng et al., 1994, 1996b; Marquart et al., 2001). A number
of recombinants with deletions within the region encoding
the 2.0-kb intron showed no change in induced reactivation,
suggesting that the LAT intron is also not essential for
induced reactivation (Jarman et al., 2002). In phenotypes
with reduced reactivation, alterations have been mapped to
the 5 portion of LAT (including the 1.5-kb region) and its
upstream sequence, along with the promoter region (Hill et
al., 1990; Trousdale et al., 1991; Sawtell and Thompson,
1992; Maggioncalda et al., 1994; Bloom et al., 1996; Saw-
tell, 1998; Loutsch et al., 1999; Perng et al., 2000b).
One viral construct with an alteration within the 1.5-kb
region is 17348, made by deleting a 348-bp region situated
between 217 and 565 bases 3 of the LAT cap site (Bloom
et al., 1996). Despite being LAT-positive, 17348 has a
significantly reduced ability to reactivate after adrenergic
induction in the rabbit ocular model; its reactivation phe-
notype is similar to that of the LAT promoter mutant
17Pst, which also has impaired ocular reactivation in rab-
bits. This combination of traits (low reactivation frequency
and LAT expression) was also found in the rabbit model
using a 370-bp deletion construct, 17Sty, on 17Syn
background (Hill et al., 1996; Loutsch et al., 1999), but not
with dLAT371 on McKrae background (Perng et al., 1996a;
Loutsch et al., 1999).
If the deletion of a single unique segment in the DNA
structure of the 348-bp region could be shown to result in
reduced in vivo reactivation, perhaps a mechanism respon-
sible for efficient induced reactivation could be elucidated.
To delineate a minimal segment within the 348-bp region
critical for efficient adrenergically induced reactivation,
three smaller nonoverlapping deletion mutants—17110,
1791, and 17116—were tested in the rabbit ocular mod-
el; all three exhibited high reactivation phenotypes similar
to that of the parent 17Syn (Bloom et al., 1996). Thus,
these recombinants failed to identify a smaller constitutive
element within the 348-bp region that facilitates reactiva-
tion; however, because they were not overlapping deletions,
the possibility remained that a critical cis-acting element
was bisected by these deletion breakpoints. Therefore, one
aim of the present study was to investigate this possibility
with two mutants that redundantly cover this region.
The primary aim of this study was to further our under-
standing of the role of the 348-bp region in the reactivation
process. Two viral recombinants with deletions in the
348-bp region, one with a 201-bp deletion at the 5 end
(17201) and the other with a 207- bp deletion at the 3 end
(17207), were constructed and assessed for reactivation
efficiency in the rabbit. The results show that both recom-
binants reactivate with the same high efficiency as the
wild-type virus, extending the results of previous studies
with smaller, nonoverlapping deletions in this region to
suggest that no discrete cis-acting element such as a key
transcription factor binding site exists in this region to
facilitate reactivation. Instead, it seems likely that a larger
portion of the 348-bp region is required to mediate its effect.
Results
Characterization of viral constructs
Three recombinant viruses were constructed as described
under Materials and methods (Fig. 1). All recombinants
were compared with the parent 17Syn for their relative
viral yield on rabbit skin (RS) cells and mouse embryo
fibroblast (MEF) cells using single- and multistep growth
analyses. No differences in viral yields were observed.
The recombinants 17201 and 17207 contained dele-
tions that collectively span the 348-bp region of 17348.
Dot blots of 17201 and 17207 virus amplified from
individual transfection plaques were probed with random
hexamer-labeled probes prepared from PCR products cor-
responding to either the 201- or the 207-bp fragments. The
recombinant plasmids were sequenced to confirm the dele-
tion breakpoints and the orientation of the recombination
arms relative to each other. The viral recombinants were
verified by Southern blot analysis to confirm that the 201 or
207 fragments were present in the restriction fragments
corresponding with the LAT region, that the viruses were
double-sided with respect to this insertion, and that the
remaining region of the 348-bp deletion (lying outside of
the 201- or 207-bp fragments) was not present in the ap-
propriate recombinants.
An EcoRI lacZ probe hybridized to a 360-bp fragment in
the EcoRI digest of the 17348St virus but not in the digests
of the parent or rescue strains.
Assessment of reactivation with 17201 and 17207
17Syn, 17Pst, 17348, and 17348R, as well as the
mutant 17201, which contained a 201-bp deletion that
represents the 5 end of the 348-bp region, and the mutant
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17207, which contained a 207-bp deletion that is equiva-
lent to the 3 end of the 348-bp region and overlaps 89 bases
of 17201 (Fig. 1), were analyzed for their reactivation
phenotypes in the rabbit eye model as described under
Materials and methods (Table 1). The two constructs,
17201 and 17207, had significantly higher reactivation
frequencies, compared with 17348 and 17Pst (P 
0.001), which exhibited low reactivation frequencies and
were included in this experiment as negative controls. The
reactivation phenotypes of both 17201 and 17207 were
not significantly different from those of the high reactiva-
tion frequency parent, 17Syn, and the rescuant, 17348R.
Effect of replacement of 348 bp of LAT with an irrelevant
sequence
To determine whether alterations in spacing outside the
348-bp region resulting from the deletion are related to the
reactivation-negative phenotype of 17348, a construct
(17348St) was made in which the deleted 348-bp region
was replaced by heterologous lacZ DNA. The in vivo re-
activation frequency of the 17348St construct was similar
to that of 17348 and significantly reduced compared to
that of 17348R (Table 2), indicating that spacing is not a
factor in the low reactivation phenotype of the deletion
mutant. The reactivation phenotypes of 17348 and
17348St were similar to that of 17Sty, a 371-bp deletion
Fig. 1. Latency-associated transcript (LAT) domain showing genomic sites numbered according to 17Syn parent sequence as published in GenBank revision
of October 24, 2001. Thick line, major 2.0-kb LAT; dashed line, LAT promoter region. Labeled genomic sites are TRL, terminal long repeat; UL, unique long;
IRL, internal repeat long; IRS, internal repeat short, US, unique short, and TRS, terminal repeat short. Location of deletion in each viral construct is depicted
below the parent sequence.
Table 1
Reactivation of 17201 and 17207 after epinephrine iontophoresisa
Virus No. positive/total (%)
Eyes Swabs [Pb]
17Syn 9/10 (90) 25/70 (36)
17Pst 1/7 (14) 2/49 (4) [0.001]
17348 4/20 (20) 8/140 (6) [0.001]
17201 14/26 (54) 58/170 (34) [0.88]
17207 17/33 (52) 69/219 (31) [0.56]
17348R 11/12 (90) 30/84 (36) [1.000]
a Cumulative results from three independent experiments.
b Statistical comparison of swab data only (Exact Version of Chi-square
analysis) with parent 17Syn.
Table 2
Reactivation of 17348St after epinephrine iontophoresisa
Virus Positive eyes/total eyes (%) Total positive swabs/
total swabsb (%)
7348R 13/17 (76) 41/119 (39)
17348 7/22 (32) 14/154 (9)
17348St 10/27 (37) 22/189 (12)
17Sty 7/20 (35) 13/140 (9)
a Cumulative data from two independent experiments.
b P  0.001 by Exact Version of Chi-square analysis for all pair-wise
comparisons with 17348R.
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construct with a known low reactivation frequency. The
parent of all the recombinant viruses was 17Syn.
Discussion
Although RT-PCR and in situ hybridization can occa-
sionally detect very small amounts of HSV-1 transcripts in
latent ganglia, the only consistent and abundant transcript
present under these conditions is LAT (Croen et al., 1987;
Deatly et al., 1987; Rock et al., 1987; Spivack and Fraser,
1987; Stevens et al., 1987; Feldman et al., 2002), which is
derived from long repeats (LR). Transcription of an 8.3-kb
LAT is regulated by the latency-associated promoter (LAP),
which is posttranscriptionally processed to yield the minor
and major LATs (Stevens et al., 1987; Wechsler et al.,
1988a; Wagner et al., 1988a; Mitchell et al., 1990). There is,
however, some variation concerning the role of LAT in the
establishment of latency in the rabbit and mouse models. In
the rabbit ocular model, LAT has been reported to have no
significant influence on the establishment and/or mainte-
nance of latency relative to HSV-1 DNA copy numbers
(Bloom et al., 1994, 1996; Perng et al., 1994; Hill et al.,
1996, 1997). More recently, however, Perng et al. (2000b)
described a two- to threefold increase in neuronal latency in
rabbits using a LAT-positive virus with EGFP as a marker,
compared with the LAT-negative EGFP carrying virus. De-
spite earlier controversy about the techniques used to deter-
mine the role of LAT in virus-induced blocking of apoptosis
(Perng et al., 2000a; Thompson and Sawtell, 2000; Wech-
sler et al., 2000), there has been growing support for the idea
that LAT blockage of neuronal apoptosis serves to maintain
HSV-1 latency (Ahmed et al., 2002; Inman et al., 2001).
In the murine latency model, also, results appear to be
paradoxical. Several investigators have reported that LAT is
involved in repression of lytic gene expression in ganglia
(Chen et al., 1997; Garber et al., 1997), whereas others have
reported that LAT has no effect on the establishment and/or
maintenance of latency in terms of viral copy numbers
(Devi-Rao et al., 1994; Chen et al., 1997; Marquart et al.,
2001) or in vitro reactivation (cocultivation) (Javier et al.,
1988; Izumi et al., 1989; Sedarati et al., 1989; Steiner et al.,
1989; Block et al., 1990; Cook et al., 1991; Farrell et al.,
1991). Nevertheless, there is little or no controversy con-
cerning the fact that the absence of LAT results in reduced
reactivation in both the mouse and the rabbit in vitro and in
vivo models (Sedarati et al., 1989; Hill et al., 1990; Cook et
al., 1991; Leib et al., 1991; Trousdale et al., 1991; Sawtell
and Thompson, 1992; Perng et al., 1994, 1999, 2000a;
Bloom et al., 1994; Devi-Rao et al., 1994; Block and Hill,
1997; Sawtell et al., 2001).
Complicating matters is the evidence that there appear to
be phenotypic differences between LAT mutants in differ-
ent HSV-1 strains, as well as in their behavior in different
animal models. For example, it has been shown that footpad
infection of mice with 17Pst results in approximately
twofold less viral DNA in latently infected ganglia than
infection with either the parent or the rescuant. However, no
such difference was seen with a homologous promoter de-
letion in strain KOS (Devi-Rao et al., 1994). A LAT pro-
moter mutant containing a deletion of the 202-bp Pst frag-
ment that was replaced with a 124-bp lacZ stuffer fragment
was examined in detail for acute replication properties in the
mouse eye; the results demonstrated that it replicated less
efficiently than wild-type 17Syn (Garber, Coen, and
Knipe, personal communication). In contrast, no such rep-
lication or establishment deficits have been observed in the
rabbit eye model, strongly suggesting the existence of spe-
cies effects in evaluating LAT recombinants.
Mechanisms by which LAT exerts its influence upon
reactivation are unclear. Zwaagstra et al. (1990) identified
the LAT promoter bearing neuronal specificity as being
located more than 660 nucleotides upstream of the 5 end of
the stable 2-kb LAT. In experiments involving rat and
mouse models, ectopic localization of LAP-1 (800 bp)
and determination of its lacZ expression activity revealed
that LAP-1-mediated -gal expression diminished over the
course of 3 weeks, suggesting that there was no completely
functional LAT promoter within the 800 bases (Fink et al.,
1992; Margolis et al., 1993; Deshmane et al., 1995). Lo-
kensgard et al. (1994), using the KOS strain of HSV-1,
presented evidence that the 5 exon of LAT (KOS) contains
an enhancer function that protects the upstream LAT pro-
moter from shutoff in the mouse model. Subsequently, Lo-
kensgard et al. (1997) reported that a 1.5-kb fragment lo-
cated immediately downstream of the LAT transcript CAP
site, named the long-term expression (LTE) element, is
required for the long-term maintenance of LAT promoter
activity. Using the rabbit ocular model, Perng et al. (2000b)
showed that a LAT-null virus on McKrae background, in
which a LAT-promoter-driven EGFP was inserted, yielded
fewer infected neurons than a LAT-positive virus with the
same EGFP insertion. In this same study, which involved a
1.8-kb LAT promoter, long-term expression of EGFP was
found without the need for the first 1.5 kb of LAT. In the
mouse model, mutational analysis within the 1.5-kb region
of HSV-1(KOS) led investigators to conclude that a 600-bp
fragment, when associated with a LAT promoter, is suffi-
cient for both enhancement and long-term expression activ-
ities (Berthomme et al., 2000, 2001). These investigators
also found that deletion of a StyI-NheI fragment at the 5
end of the LTE sequence resulted in a loss of the enhancer
function. The StyI-NheI deletion included the same 348-bp
region described in the 17Syn background strain used in
the rabbit ocular model by Bloom et al. (1996). It was
deduced that there is a strong correlation between epineph-
rine-induced reactivation, which depends on the entire
348-bp region, and the enhancer activity (Lokensgard et al.,
1997).
Previous reports have suggested that motifs in the LAP-2
region of HSV-1 (described by Goins et al., 1994, as a
second promoter, comprising a region between LAP-1 and
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the LAT intron) facilitate the binding of Sp1 transcription
factors (French et al., 1996). The 348-bp region contains
three ATGs that could act as translation initiators for three
LAT-encoded ORFs with predicted coding capacities of 54,
60, and 116 amino acids. Site-directed mutagenesis of three
ATGs in the 348-bp region produced no changes in reacti-
vation phenotypes, compared with the parent virus, nor
were small deletions within the 348-bp region sufficient to
alter reactivation (Bloom et al., 1996). This could indicate a
spatial arrangement that is critical for transcription factor
binding. Therefore, to assess whether the reactivation effi-
ciency is determined by the nucleotide sequence or the
position of the sequence outside of the 348-bp region, a viral
construct was prepared in which the 348-bp deletion was
replaced with a 360-bp heterologous DNA (lacZ). This
construct (17348St) had a low reactivation frequency sim-
ilar to that of 17348, indicating that the spacing and/or
position of elements outside of the 348-bp region do not
regulate reactivation.
In the present study, removal of the 5 end (207 bp) or
the 3 end (201 bp) of the 348-bp region produced reacti-
vation phenotypes and LAT expression not significantly
different from the wild-type phenotype, suggesting that
these deletions have no major effect on induced reactiva-
tion. However, mutants with the 370-bp deletion (17Syn)
(Hill et al., 1996; Loutsch et al., 1999) or 348-bp deletion
(Bloom et al., 1996) within the 1.5-kb region demonstrated
reduced reactivation phenotypes in the rabbit model. This
information, coupled with the unaffected expression of
LAT, suggest that these regions may enhance LAT-depen-
dent in vivo induced reactivation.
The lack of effect of smaller subdeletions within the
348-bp region (Bloom et al., 1996) on reactivation pheno-
type, as well as the results of our study reported here,
suggest that these smaller regions compensate for one an-
other in terms of enhancement of induced reactivation.
Moreover, the wild-type phenotypes associated with these
smaller deletions within the 348-bp region, as well as the
persistent expression of LAT under these conditions, sug-
gest the possibility that the compensatory region of LAT
may lie in the upstream and/or downstream sequences of
these regions.
One limitation of our study is that the 3 end of the
mutant with the 207-bp deletion is 26 bp shorter than the 3
end of 17348. Further study is required to determine
whether these 26 bases are critical to reactivation. Attempts
will also be made to generate 17flip348 and 17invert348
constructs. The 17flip348 construct will have the 348-bp
region in the reverse orientation. The 17invert348 construct
will have the 348-bp region in an antisense polarity (5–3).
Our rationale is that a region having a central role in reac-
tivation might contain elements in the left-to-right orienta-
tion and/or sense that could provide clues as to its function.
If this activity is due to a promoter, one would expect the
mechanism to be directional. If both of the constructs dis-
play decreased reactivation, it would suggest that this region
contributes a specific enhancer-like activity rather than that
of a promoter.
Materials and methods
Cells and viruses
Primary rabbit kidney (PRK) cells, RS cells, and MEF
cells in Earle’s minimum essential medium (Gibco Life
Technologies, Grand Island, NY) with 10% fetal bovine
serum were used to propagate the viruses. Plaque assays
were performed on CV-1 (African green monkey) cells. The
presence of infectious virus in reactivation experiments was
assessed by placing tear film swabs in a tube containing a
confluent monolayer of PRK cells. The swabs were re-
moved after 48 h and the monolayers were examined for
cytopathic effect (CPE). All viral constructs were made on
the 17Syn parental background.
Construction of recombinants
To construct 17348St, the stuffer fragment was inserted
in place of the 348-bp region that was deleted in 17348.
The stuffer sequence was a 360-bp fragment from the Esch-
erichia coli lacZ gene. This fragment was excised as a PvuII
fragment from the plasmid pCAL [obtained from Dr. Ed-
ward Wagner and described previously (Huang et al.,
1994)].
The left arm for generating the 201-bp deletion (nt
119,010–119,211) was generated with the PCR primers 5
GGA TCC GAT ATC AAT CCG TTA AGT GCT CTG 3
and 5 GAA TTC GAA GCA AAA ACA CCC CAG ACG
GGT 3. The resulting PCR product was digested with
EcoR1 and BamH1, gel purified, and cloned into the same
sites of pBlueScript SK(). The right arm of the recombi-
nation plasmid was generated with the primers 5 GAA
TTC CCC TGG CGG CCC GGC C 3 and 5 GCA AGC
TTA TGC CTT CTT GGA GTA CGT GGG 3. The result-
ing PCR product was digested with EcoR1 and HindIII, gel
purified, and cloned into the pBlueScript SK() plasmid
containing the left recombination arm that had been di-
gested with EcoR1 and HindIII and column purified to
remove the resulting linker fragment. The fragment and
plasmid were then ligated and used to rescue 17348 by
cotransfection with purified 17348 virion DNA.
The left recombination arm for generating the 207-bp
deletion (nt 119,122– 119,329) was generated with the PCR
primers 5 GGA TCC GAT ATC AAT CCG TAA AGT
GCT CTG CAG GGG 3 and 5 GAA TTC GCC GGC
GAG CGG GTC CGG AGC 3. The resulting PCR product
was digested with EcoR1 and BamH1, gel purified, and
cloned into the same sites of pBlueScript SK(). The right
arm of the recombination plasmid was generated with the
primers 5 GAA TTC CGC CTT TCC TGT TCT CGC TTC
TTC 3 and 5 GCA AGC TTA TGC CTT CTT GGA GTA
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CGT GGG 3. The resulting PCR product was digested with
EcoR1 and HindIII, gel purified, and cloned into the same sites
of pBlueScript SK(), containing the left recombination arm
that had been digested with EcoR1 and HindIII, and column
purified to remove the resulting linker fragment. The fragment
and plasmid were then ligated and used to rescue 17348 by
cotransfection with purified 17348 virion DNA.
In all cases, the cotransfection method to generate the
recombinants was carried out by calcium phosphate copre-
cipitation in RS cells, and the recombinants were screened
and plaque-purified by previously published methods
(Bloom, 1996). For the cotransfection, 1 g of recombina-
tion plasmid and 10 g of purified virion DNA were used.
Construction of 17348 (Bloom et al., 1996) and 17Sty
(Maggioncalda et al., 1994; Hill et al., 1996; Loutsch et al.,
1999) have been described previously. All base-pair num-
bers are referred to as the corresponding positions in the
published HSV-1 sequence of strain 17Syn as revised and
presented in GenBank (g1944536).
Ocular inoculation of rabbits
To examine induced reactivation in vivo, rabbits were
inoculated with 17201, 17207, or 17348St. 17Sty,
17Pst, and 17348 were included as reactivation-negative
controls, and 17348R and 17Syn were included as re-
activation-positive controls. Inoculations with the viruses
were done in mildly scarified eyes (2  2 cross hatch).
Rabbits received 2  105 PFU of virus in 50 l of tissue
culture medium. The acute infection was monitored by
slit-lamp microscopy; all eyes demonstrated dendritic le-
sions on postinfection (PI) days 3 through 7 (Hill et al.,
1993).
Adrenergic induction of reactivation
Rabbits were considered latently infected when the cor-
neal epithelium was observed to be intact (PI day 21).
Latently infected rabbits were induced to reactivate by
transcorneal iontophoresis of epinephrine (Hill et al., 1987,
1990, 1996). Briefly, New Zealand white rabbits approxi-
mately 2 kg in body weight were inoculated with 2  105
PFU of a given virus construct in each scarified eye. Epi-
nephrine induction was begun 4 to 5 weeks after primary
infection, after at least 3 to 5 days in which no viral shed-
ding was observed. Transcorneal iontophoresis of 0.01%
epinephrine (0.8 mA for 8 min) was performed daily for
three consecutive days. Following induction, eye swabs
were collected daily for 7 days to assess for reactivated
virus in culture.
Statistical analysis
Statistical analyses were performed using the Exact Ver-
sion of the Chi-square test. Results were considered statis-
tically significant when the P value was 0.05.
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